概览

Tutorials: October 26*
Tutorial #1- Plain Language Labeling: Implementing Health Canada's Guidance for Industry
Tutorial #2- Strategies for Efficient Submission Preparation
*Tutorials require registration and are an additional fee

Meeting: October 27-28

A New Era in Regulatory Affairs - Building Capabilities to Support Innovation, Transparency, Quality and Safety of Health Products in Canada

As the Canadian health care system continues to evolve, the need for transparency is playing an important role in the development and management of new and existing medicines and devices. Numerous stakeholders are working to build regulatory capabilities that will help to promote innovation and to maintain high standards of quality and safety of important therapies and medicines in Canada.

The DIA Annual Canadian Meeting 2015 will bring together key thought leaders and experts, representing various stakeholders, to explore what this new era of regulatory affairs means to the Canadian health care and biopharmaceutical industries.

This year’s meeting will feature plenary sessions, multi-track breakout sessions, networking opportunities, tutorials and tabletop exhibiting opportunities.

Featured

Want to learn more about DIA Annual Canadian Meeting 2015? You've come to the right site!

谁应该参加？

Professionals involved in:

学习目标

At the conclusion of this meeting, participants should be able to:

Describe the current and evolving regulatory environment in Canada
Recognize the challenges faced by various Canadian stakeholders in the development, regulation, and harmonization of, accessing the state-of-the-art medicines and devices within a global context
Discuss new technologies and efficiencies to support drug and device development
Describe quality measures to support improved inspections and manufacturing practices

Short Course or Primer

To keep you at the forefront.

2015 年 10 月 26 日

Tutorial-1-Plain-Language-Labeling-Implementing-Heralth-Canada-s-Guidance-for-Industry:

了解更多

2015 年 10 月 26 日

Tutorial-2-Strategies-for-Efficient-Submission-Preparation:

了解更多

2015 年 10 月 26 日

Tutorial-1-Plain-Language-Labeling-Implementing-Heralth-Canada-s-Guidance-for-Industry:

了解更多

2015 年 10 月 26 日

Tutorial-2-Strategies-for-Efficient-Submission-Preparation:

了解更多

项目委员会

Karen Feltmate President
Redstone Health Group, Inc., Canada
Matthew Ryan Senior Policy Analyst; Policy, Planning and International Affairs Directorate
Health Canada, Canada
Marilena Bassi, MA Senior Executive Director, Therapeutic Products Directorate
Health Canada, Canada
Rocelyn DelCarmen Director, Regulatory Affairs and Quality Assurance
Astrazeneca Canada Inc., Canada
Maggie Graham Senior Policy Analyst, Natural and Non-Prescription Health Products Directorate
Health Canada, Canada
Vratislav Hadrava, MD, PHD Vice President and Medical Director, Global Innovative Products
Pfizer Canada, Inc., Canada
Ljubica Ivanisevic, PHD Scientific Evaluator
Health Canada, Canada
Chanez Narimene Kebache, MBA Director, Global Product Safety & Pharmacovigilance
Canopy Growth Corporation, Canada
Marc Poitras, PHD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada